Literature DB >> 4166042

Studies on the proteolytic activity of gamma-globulin preparations.

B Robert, R S Bockman.   

Abstract

1. The proteolytic activities of several gamma-globulin preparations were tested. These included sulphate-precipitated human and bovine preparations and human and bovine Cohn fraction II preparations as well as purified gamma-globulin preparations. Up to 14mg. of diffusible peptides and glycopeptides/g. of gamma-globulin was liberated after dialysis and up to 10mg. of peptides/g. after incubation and trichloroacetic acid precipitation, as products of the degradation process in incubated gamma-globulin. 2. in-Aminohexanoic acid and p-chloromercuribenzoic acid, as well as heating at 60 degrees for 40min., were shown to inhibit strongly these proteolytic activities. Streptokinase was shown to activate strongly the proteolytic activity of all the human preparations (sulphate-precipitated, Cohn fraction II, and purified gamma-globulin). 3. Two distinct pH optima were shown for human and bovine gamma-globulin preparations: one at pH8, the other at pH3.8 (the latter activity could be demonstrated only in the presence of cysteine). 4. Both (131)I-labelled human Cohn fraction II and bovine fibrinogen were attacked by a sulphate-precipitated preparation of gamma-globulin. Of the synthetic substrates tested toluene-p-sulphonyl-l-arginine methyl ester was hydrolysed by both the sulphate-precipitated and Cohn fraction II preparations, as was benzoyl-l-arginine amide at pH5, but only in the presence of cysteine. 5. These data are interpreted to indicate that at least two enzymes are present in gamma-globulin preparations, one being similar to the plasmin system, the other similar to cathepsin B.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4166042      PMCID: PMC1270280          DOI: 10.1042/bj1020554

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  [MECHANISM OF THE LIBERATION OF DIALYZABLE PEPTIDES FROM GAMMA-GLOBULINS].

Authors:  R BOCKMAN; Y CREPIN; B ROBERT
Journal:  C R Hebd Seances Acad Sci       Date:  1965-03-22

2.  The effects of guinea-pig gamma globulins on capillary permeability and serum complement.

Authors:  G E DAVIES; J S LOWER
Journal:  Immunology       Date:  1961-10       Impact factor: 7.397

3.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

4.  Inhibition of plasmin, trypsin and the streptokinase-activated fibrinolytic system by 6-aminocaproic acid.

Authors:  F B ABLONDI; J J HAGAN; M PHILIPS; E C DE RENZO
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

5.  Protein chromatography on ion exchange cellulose.

Authors:  H A SOBER; E A PETERSON
Journal:  Fed Proc       Date:  1958-12

6.  The hydrolysis of rabbit y-globulin and antibodies with crystalline papain.

Authors:  R R PORTER
Journal:  Biochem J       Date:  1959-09       Impact factor: 3.857

7.  Measurement of the rate of plasmin action on synthetic substrates.

Authors:  P S ROBERTS
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

8.  [Effect of the quantity of iodine fixed on normal and heat-modified blood proteins on the phagocytosis of these colloids by reticuloendothelial cells].

Authors:  B BENACERRAF; G BIOZZI; B N HALPERN; D MOUTON; C STIFFEL
Journal:  Ann Inst Pasteur (Paris)       Date:  1957-01

9.  Serum glyco protein concentrations in experimental tuberculosis of guinea pigs.

Authors:  H E WEIMER; J R MOSHIN
Journal:  Am Rev Tuberc       Date:  1953-10

10.  The serum proteins in multiple myelomatosis.

Authors:  R A Kekwick
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

View more
  1 in total

1.  One cell-one immunoglobulin. Origin of limited heterogeneity of myeloma proteins.

Authors:  Z L Awdeh; A R Williamson; B A Askonas
Journal:  Biochem J       Date:  1970-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.